FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation

Wen Zhou, Qian Cao, Yan Peng, Qing Jun Zhang, Diego H. Castrillon, Ronald A. DePinho, Zhi Ping Liu

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Background & Aims: FoxO4 is a member of the forkhead box transcription factor O (FoxO) subfamily. FoxO proteins are involved in diverse biological processes. In this study, we examine the role of FoxO4 in intestinal mucosal immunity and inflammatory bowel disease (IBD). Methods: Foxo4-null mice were subjected to trinitrobenzene sulfonic acid (TNBS) treatment. Microarray analysis and quantitative reverse transcription polymerase chain reaction were used to identify the cytokine transcripts that were altered by Foxo4 deletion. The effects of Foxo4 deficiency on the intestinal epithelial permeability and levels of tight junction proteins were examined by permeable fluorescent dye and Western blot. The molecular and cellular mechanisms by which FoxO4 regulates the mucosal immunity were explored through immunologic and biochemical analyses. The expression level of FoxO4 in intestinal epithelial cells of patients with IBD was examined with immunohistochemistry. Results: Foxo4-null mice were more susceptible to TNBS injury-induced colitis. The chemokine CCL5 is significantly up-regulated in the colonic epithelial cells of Foxo4-null mice, with increased recruitment of CD4+ intraepithelial T cells and up-regulation of cytokines interferon-γ and tumor necrosis factor-α in the colon. Foxo4 deficiency also resulted in an increase in intestinal epithelial permeability and down-regulation of the tight junction proteins ZO-1 and claudin-1. Mechanistically, FoxO4 inhibited the transcriptional activity of nuclear factor-κB (NF-κB), and Foxo4 deficiency is associated with increased NF-κB activity in vivo. FoxO4 transcription is transiently repressed in response to TNBS treatment and in patients with IBD. Conclusion: These results indicate that FoxO4 is an endogenous inhibitor of NF-κB and identify a novel function of FoxO4 in the regulation of NF-κB-mediated mucosal immunity.

Original languageEnglish (US)
Pages (from-to)1403-1414
Number of pages12
JournalGastroenterology
Volume137
Issue number4
DOIs
StatePublished - Oct 2009

Fingerprint

Trinitrobenzenes
Mucosal Immunity
Sulfonic Acids
Inflammatory Bowel Diseases
Inflammation
Permeability
Wounds and Injuries
Epithelial Cells
Zonula Occludens-1 Protein
Claudin-1
Cytokines
Forkhead Transcription Factors
Tight Junction Proteins
Biological Phenomena
Chemokine CCL5
Colitis
Microarray Analysis
Fluorescent Dyes
Interferons
Reverse Transcription

ASJC Scopus subject areas

  • Gastroenterology

Cite this

FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation. / Zhou, Wen; Cao, Qian; Peng, Yan; Zhang, Qing Jun; Castrillon, Diego H.; DePinho, Ronald A.; Liu, Zhi Ping.

In: Gastroenterology, Vol. 137, No. 4, 10.2009, p. 1403-1414.

Research output: Contribution to journalArticle

Zhou, Wen ; Cao, Qian ; Peng, Yan ; Zhang, Qing Jun ; Castrillon, Diego H. ; DePinho, Ronald A. ; Liu, Zhi Ping. / FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation. In: Gastroenterology. 2009 ; Vol. 137, No. 4. pp. 1403-1414.
@article{26664cd7aa4f4611b3a3b9478b9c759d,
title = "FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation",
abstract = "Background & Aims: FoxO4 is a member of the forkhead box transcription factor O (FoxO) subfamily. FoxO proteins are involved in diverse biological processes. In this study, we examine the role of FoxO4 in intestinal mucosal immunity and inflammatory bowel disease (IBD). Methods: Foxo4-null mice were subjected to trinitrobenzene sulfonic acid (TNBS) treatment. Microarray analysis and quantitative reverse transcription polymerase chain reaction were used to identify the cytokine transcripts that were altered by Foxo4 deletion. The effects of Foxo4 deficiency on the intestinal epithelial permeability and levels of tight junction proteins were examined by permeable fluorescent dye and Western blot. The molecular and cellular mechanisms by which FoxO4 regulates the mucosal immunity were explored through immunologic and biochemical analyses. The expression level of FoxO4 in intestinal epithelial cells of patients with IBD was examined with immunohistochemistry. Results: Foxo4-null mice were more susceptible to TNBS injury-induced colitis. The chemokine CCL5 is significantly up-regulated in the colonic epithelial cells of Foxo4-null mice, with increased recruitment of CD4+ intraepithelial T cells and up-regulation of cytokines interferon-γ and tumor necrosis factor-α in the colon. Foxo4 deficiency also resulted in an increase in intestinal epithelial permeability and down-regulation of the tight junction proteins ZO-1 and claudin-1. Mechanistically, FoxO4 inhibited the transcriptional activity of nuclear factor-κB (NF-κB), and Foxo4 deficiency is associated with increased NF-κB activity in vivo. FoxO4 transcription is transiently repressed in response to TNBS treatment and in patients with IBD. Conclusion: These results indicate that FoxO4 is an endogenous inhibitor of NF-κB and identify a novel function of FoxO4 in the regulation of NF-κB-mediated mucosal immunity.",
author = "Wen Zhou and Qian Cao and Yan Peng and Zhang, {Qing Jun} and Castrillon, {Diego H.} and DePinho, {Ronald A.} and Liu, {Zhi Ping}",
year = "2009",
month = "10",
doi = "10.1053/j.gastro.2009.06.049",
language = "English (US)",
volume = "137",
pages = "1403--1414",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation

AU - Zhou, Wen

AU - Cao, Qian

AU - Peng, Yan

AU - Zhang, Qing Jun

AU - Castrillon, Diego H.

AU - DePinho, Ronald A.

AU - Liu, Zhi Ping

PY - 2009/10

Y1 - 2009/10

N2 - Background & Aims: FoxO4 is a member of the forkhead box transcription factor O (FoxO) subfamily. FoxO proteins are involved in diverse biological processes. In this study, we examine the role of FoxO4 in intestinal mucosal immunity and inflammatory bowel disease (IBD). Methods: Foxo4-null mice were subjected to trinitrobenzene sulfonic acid (TNBS) treatment. Microarray analysis and quantitative reverse transcription polymerase chain reaction were used to identify the cytokine transcripts that were altered by Foxo4 deletion. The effects of Foxo4 deficiency on the intestinal epithelial permeability and levels of tight junction proteins were examined by permeable fluorescent dye and Western blot. The molecular and cellular mechanisms by which FoxO4 regulates the mucosal immunity were explored through immunologic and biochemical analyses. The expression level of FoxO4 in intestinal epithelial cells of patients with IBD was examined with immunohistochemistry. Results: Foxo4-null mice were more susceptible to TNBS injury-induced colitis. The chemokine CCL5 is significantly up-regulated in the colonic epithelial cells of Foxo4-null mice, with increased recruitment of CD4+ intraepithelial T cells and up-regulation of cytokines interferon-γ and tumor necrosis factor-α in the colon. Foxo4 deficiency also resulted in an increase in intestinal epithelial permeability and down-regulation of the tight junction proteins ZO-1 and claudin-1. Mechanistically, FoxO4 inhibited the transcriptional activity of nuclear factor-κB (NF-κB), and Foxo4 deficiency is associated with increased NF-κB activity in vivo. FoxO4 transcription is transiently repressed in response to TNBS treatment and in patients with IBD. Conclusion: These results indicate that FoxO4 is an endogenous inhibitor of NF-κB and identify a novel function of FoxO4 in the regulation of NF-κB-mediated mucosal immunity.

AB - Background & Aims: FoxO4 is a member of the forkhead box transcription factor O (FoxO) subfamily. FoxO proteins are involved in diverse biological processes. In this study, we examine the role of FoxO4 in intestinal mucosal immunity and inflammatory bowel disease (IBD). Methods: Foxo4-null mice were subjected to trinitrobenzene sulfonic acid (TNBS) treatment. Microarray analysis and quantitative reverse transcription polymerase chain reaction were used to identify the cytokine transcripts that were altered by Foxo4 deletion. The effects of Foxo4 deficiency on the intestinal epithelial permeability and levels of tight junction proteins were examined by permeable fluorescent dye and Western blot. The molecular and cellular mechanisms by which FoxO4 regulates the mucosal immunity were explored through immunologic and biochemical analyses. The expression level of FoxO4 in intestinal epithelial cells of patients with IBD was examined with immunohistochemistry. Results: Foxo4-null mice were more susceptible to TNBS injury-induced colitis. The chemokine CCL5 is significantly up-regulated in the colonic epithelial cells of Foxo4-null mice, with increased recruitment of CD4+ intraepithelial T cells and up-regulation of cytokines interferon-γ and tumor necrosis factor-α in the colon. Foxo4 deficiency also resulted in an increase in intestinal epithelial permeability and down-regulation of the tight junction proteins ZO-1 and claudin-1. Mechanistically, FoxO4 inhibited the transcriptional activity of nuclear factor-κB (NF-κB), and Foxo4 deficiency is associated with increased NF-κB activity in vivo. FoxO4 transcription is transiently repressed in response to TNBS treatment and in patients with IBD. Conclusion: These results indicate that FoxO4 is an endogenous inhibitor of NF-κB and identify a novel function of FoxO4 in the regulation of NF-κB-mediated mucosal immunity.

UR - http://www.scopus.com/inward/record.url?scp=70349507649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349507649&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2009.06.049

DO - 10.1053/j.gastro.2009.06.049

M3 - Article

VL - 137

SP - 1403

EP - 1414

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -